Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
DisGeNET
DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
| Source | Last Updated |
|---|---|
| DisGeNET | July 29, 2024 |
| Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▼ |
|---|---|---|---|---|---|
| C0036341 | Schizophrenia | HSD17B12 | 51144 | hydroxysteroid 17-beta dehydrogenase 12 | Q53GQ0 |
| C0007097 | Carcinoma | HSD17B12 | 51144 | hydroxysteroid 17-beta dehydrogenase 12 | Q53GQ0 |
| C2239176 | Liver carcinoma | PARP10 | 84875 | poly(ADP-ribose) polymerase family member 10 | Q53GL7 |
| C0235974 | Pancreatic carcinoma | PARP10 | 84875 | poly(ADP-ribose) polymerase family member 10 | Q53GL7 |
| C0004135 | Ataxia Telangiectasia | PARP10 | 84875 | poly(ADP-ribose) polymerase family member 10 | Q53GL7 |
| C0005586 | Bipolar Disorder | PARP10 | 84875 | poly(ADP-ribose) polymerase family member 10 | Q53GL7 |
| C0346647 | Malignant neoplasm of pancreas | PARP10 | 84875 | poly(ADP-ribose) polymerase family member 10 | Q53GL7 |
| C0236773 | Depressed bipolar I disorder | PARP10 | 84875 | poly(ADP-ribose) polymerase family member 10 | Q53GL7 |
| C0524851 | Neurodegenerative Disorders | PARP10 | 84875 | poly(ADP-ribose) polymerase family member 10 | Q53GL7 |
| C0028866 | Oculomotor Nerve Paralysis | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
| C0948008 | Ischemic stroke | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
| C0020635 | Hypopituitarism | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
| C0007785 | Cerebral Infarction | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
| C0038454 | Cerebrovascular accident | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
| C0007222 | Cardiovascular Diseases | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
| C0524620 | Metabolic Syndrome X | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
| C0852949 | Arteriopathic disease | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
| C0028840 | Ocular Hypertension | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
| C0086543 | Cataract | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
| C0002871 | Anemia | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
| C0917996 | Cerebral Aneurysm | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
| C0153633 | Malignant neoplasm of brain | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
| C1837461 | SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3 | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
| C1861172 | Venous Thromboembolism | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
| C0014544 | Epilepsy | ACSM3 | 6296 | acyl-CoA synthetase medium chain family member 3 | Q53FZ2 |
